U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07442903) titled 'PA Pressure Monitoring in Patients With Tricuspid Regurgitation' on Feb. 17.
Brief Summary: Tricuspid regurgitation (TR) is a severe and highly prevalent disease that leads to right-sided heart failure. The severity of TR is associated with increasing morbidity and mortality. While severe TR and right-sided heart failure have an impact on the quality of life and prognosis of the individual patient, repeat heart failure hospitalizations challenge limited hospital resources on an institutional level and stress the medical health care system on an economic level. Transcatheter valve interventions (TTVI) including transcatheter tricuspi...